No superiority of treatment with osmotic controlled-release oral delivery system-methylphenidate over short/medium-acting methylphenidate preparations in the rate and timing of injuries in children with attention-deficit/hyperactivity disorder

Pavel Golubchik, Arad Kodesh, Abraham Weizman

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'No superiority of treatment with osmotic controlled-release oral delivery system-methylphenidate over short/medium-acting methylphenidate preparations in the rate and timing of injuries in children with attention-deficit/hyperactivity disorder'. Together they form a unique fingerprint.

Medicine & Life Sciences